Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Acquisition of Controlling Interest in a Phytomedical Company

Represented an investor in the acquisition of a controlling interest in Palliatech, Inc., a phytomedical company focused on the therapeutic value of medical cannabis.